Live Analyst Rating Changes 19732 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Daniel Arias
STIF

Daniel Arias

Stifel Nicolaus
Wall Street Analyst
★★★★☆
#385
on 13Foresight · ranked by our own returns
59%
Success Rate
+11.1%
Average Return
24 of 41 calls profitable · +7.8% vs benchmark
S&P 500 (SPY)
🔒 5-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 59% of Daniel Arias's ratings turned a profit when each position was held for 1 year — averaging +11.1% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

67 Buy 35 Hold 0 Sell
Daniel's Stock Coverage 24 ratings · 2026-08-07
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
QGEN
Qiagen
 Aug 06, 2026 HOLD Buy
+0.5% avg upside
24 analysts
$36.00
13.73% Downside
 · ·
BLLN
BillionToOne, Inc. Class A
 Aug 06, 2026 BUY Strong Buy
+32.9% avg upside
9 analysts
$145.00
58.17% Upside
 +1.9% ·
WAT
Waters
 Aug 05, 2026 HOLD Strong Buy
-2.2% avg upside
30 analysts
$420.00
5.13% Upside
 -0.1% ·
BRKR
Bruker
 Aug 05, 2026 HOLD Buy
+11.2% avg upside
22 analysts
$50.00
2.38% Downside
 +1.0% ·
TMO
Thermo Fisher
 Aug 05, 2026 BUY Strong Buy
+4.3% avg upside
38 analysts
$650.00
12.02% Upside
 · ·
RVTY
Revvity
 Aug 05, 2026 HOLD Buy
-6.3% avg upside
23 analysts
$110.00
3.78% Downside
 +0.0% ·
ILMN
Illumina
 Aug 04, 2026 BUY Buy
-9.4% avg upside
31 analysts
$225.00
16.16% Upside
 -5.2% ·
MTD
Mettler-Toledo
 Aug 03, 2026 BUY Buy
-14.5% avg upside
18 analysts
$1600.00
12.57% Upside
 -1.6% ·
TEM
Tempus AI, Inc. Class A
 Aug 03, 2026 HOLD Buy
+41.5% avg upside
21 analysts
$50.00
8.48% Upside
 +13.0% ·
GH
Guardant Health
 Aug 03, 2026 BUY Strong Buy
+3.4% avg upside
31 analysts
$180.00
14.31% Upside
 +4.7% ·
AVTR
Avantor
 Jul 30, 2026 HOLD Buy
+17.3% avg upside
26 analysts
$15.00
13.74% Upside
 -2.7% ·
RGEN
Repligen
 Jul 29, 2026 BUY Strong Buy
+8.8% avg upside
25 analysts
$207.00
29.92% Upside
 +9.4% ·
MXCT
MaxCyte
 Jul 22, 2026 BUY Buy
+260.5% avg upside
5 analysts
$4.00
260.46% Upside
 -8.8% ·
DHR
Danaher
 Jul 22, 2026 BUY Strong Buy
+5.5% avg upside
45 analysts
$220.00
10.00% Upside
 +11.6% ·
ALMR
Alamar Biosciences, Inc.
 Jun 09, 2026 BUY Strong Buy
+11.4% avg upside
5 analysts
$28.00
0.27% Downside
 +26.0% ·
A
Agilent
 May 28, 2026 BUY Strong Buy
+5.2% avg upside
33 analysts
$170.00
20.29% Upside
 +8.0% ·
RPID
Rapid Micro Biosystems
 May 14, 2026 BUY Strong Buy
+320.7% avg upside
6 analysts
$8.00
284.69% Upside
 -10.3% ·
MRVI
Maravai Lifesciences Holdings
 May 11, 2026 BUY Strong Buy
+127.8% avg upside
17 analysts
$6.00
3.91% Downside
 +31.9% ·
MASS
908 Devices
 May 07, 2026 BUY Strong Buy
+31.7% avg upside
4 analysts
$10.00
20.45% Upside
 -4.6% ·
TECH
Bio-Techne
 May 07, 2026 HOLD Buy
+16.0% avg upside
21 analysts
$50.00
30.44% Downside
 +41.5% ·
TXG
10x Genomics
 Mar 02, 2026 BUY Buy
-23.6% avg upside
18 analysts
$25.00
45.19% Downside
 +105.1% ·
CDXS
Codexis
 Nov 10, 2025 BUY Strong Buy
+593.3% avg upside
13 analysts
$5.00
237.81% Upside
 -16.0% ·
ABSI
AbSci
 Jan 22, 2025 HOLD Strong Buy
+45.4% avg upside
18 analysts
 — -21.6% ·
RNLXY
Renalytix
 Mar 01, 2024 BUY Strong Buy
+331.4% avg upside
5 analysts
$5.00
100.37% Upside
 · ·
🔒 19 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Daniel Arias — Frequently Asked Questions
How accurate are Daniel Arias's stock ratings?
Based on the calls 13Foresight could measure, about 57% of Daniel's ratings were profitable over a one-year hold, with an average return of +12.2% per rating, or +8.9% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Daniel ranked on 13Foresight?
Daniel Arias is currently ranked #385 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Daniel cover?
Daniel most recently has ratings on QGEN, BLLN, WAT, BRKR, TMO, RVTY, ILMN, MTD, TEM, GH, AVTR, RGEN and 12 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.